Drug Pipeline

Mark Cuban Says he Has the Prescription for High, Opaque Drug Pricing

April 12, 2022

Cuban, an investor on “Shark Tank” and owner of the NBA’s Dallas Mavericks, has launched a namesake online pharmacy that says it will have transparent pricing and will bypass pharmacy benefit managers.

Multiple Sclerosis - Some Drugs New, Some Tried-and-True

April 10, 2022

The race is on to be the first-approved Bruton tyrosine kinase inhibitor. Meanwhile, trials are underway to test statins and metformin as treatments for multiple sclerosis.

Fourth Shot is Recommended for the Immunocompromised

March 10, 2022

Getting boosted is now the rule, not the exception, when it comes to COVID-19 vaccination recommendations. The CDC now recommends that everyone, ages 12 and older, get a dose of an mRNA COVID-19 vaccine, either Pfizer’s or Moderna’s. For people who have gotten the two-shot Pfizer or Moderna series, the booster is their third jab. For those who got the single-dose Johnson & Johnson vaccine, it is the second.

HIV Prevention, Treatment: Playing the Long Game

February 02, 2022

Drug manufacturers are developing long-acting, injectable HIV drugs for both treatment and prevention.

The Pipeline is Full and Brimming with Promise. Hat Tip to Science.

January 06, 2022

2021 was a year in which investigators, government officials and drug companies overcame immense challenges to develop successful vaccines against COVID-19. That spirit of innovation is expected to carry over into this year.

Digital Therapeutics Shaping the Future of Care

December 14, 2021

Prescription digital therapeutics are FDA approved and available only by prescription. Their developers are aiming to get them covered by insurers.

NSCLC Therapy is Increasingly Targeted

December 08, 2021

Drugs in development and newly approved drugs for non-small cell lung cancer are based on research that has identified driver mutations leading to runaway cell growth and division that characterize cancer.

Pipeline for Atopic Dermatitis is Full — and Full of Promise, but…

November 05, 2021

Safety concerns may limit JAK inhibitors as treatment for the common skin condition.

Drugmakers Look to Quell COVID-19 Cytokine Storms

October 06, 2021

The FDA rejected Humanigen’s application for an emergency use authorization, but the race is on to develop an effective therapy for the cytokine storms that affect patients with COVID-19.

Promising Liver Disease Drugs in the Pipeline for 2021 to 2022

September 03, 2021

Three notable medications to treat liver diseases are expected to come online in the third quarter of 2021 and in 2022, according to PBM OptumRx.